Skip to main content

Table 4 Numbers of participants and prevalence in the year 1 survey, by study type and country

From: Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries

Age group Variable Study - country
Sm2 - Kenya Sm2 - Tanzania Sh2 – Mozambique Sh2 – Niger Sm1 - Côte d’Ivoire Sm1 - Kenya Sh1 - Niger
5–8 years Number enrolled 4,725 12,359 7,463 13,553 4,812 1,609 6,667
Prevalence (%) 35.7 38.5 63.1 24.0 5.3 5.8 3.3
9–12 years Number enrolled 11,541 14,620 7,317 14,249 7,410 4,614 6,682
Prevalence (%) 62.7 55.5 66.6 21.3 20.9 17.7 4.2
Adults (20–55 years) Number enrolled 7,107 4,922 4,259 7,041 N/A N/A N/A
Prevalence (%) 44.7 28.1 44.8 11.3 N/A N/A N/A
Total Number enrolled 23,373 31,901 19,039 34,843 12,222 6,223 13,349
  1. N/A not assessed, Sh1 sustaining control study in S. haematobium endemic villages, Sh2 gaining control study in S. haematobium endemic villages, Sm1 sustaining control study in S. mansoni endemic villages, Sm2 gaining control study in S. mansoni endemic villages